Growth Opportunities in the US Prenatal Genetic Testing Market, Forecast to 2021

Growth Opportunities in the US Prenatal Genetic Testing Market, Forecast to 2021

Rising Maternal Age, Improved Screening Algorithms Catering to Healthcare Payer Requirements, and Exploration of New Business Models Will Drive Market

RELEASE DATE
21-Jul-2017
REGION
North America
Research Code: K1C4-01-00-00-00
SKU: HC02850-NA-MR_20433
AvailableYesPDF Download
$4,950.00
In stock
SKU
HC02850-NA-MR_20433
$4,950.00
DownloadLink
ENQUIRE NOW

Description

Prenatal genetic tests, which are predominantly used to test disorders such as aneuploidies in chromosomes 21, 18, and 13, and carrier screens, are gaining momentum in the United States due to enhanced assay outcomes through non-invasive methodologies, increased popularity through social media channels, and the growing number of women choosing to undergo pregnancy at an advanced maternal age. The growth in demand has led to a high level of merger and acquisition activity, apart from numerous collaborations, which in turn has bolstered the product portfolio of several companies in the women’s healthcare segment. With this accelerated growth, companies are exploring new avenues to market their products, thereby strategically tying up with IVF clinics, physicians, and OBGYNs. New business models like direct to consumer (DTC) are seeing increased uptake due to ease of use and hassle-free processing. Partnerships with Big Data companies will be the next big leap in the prenatal genetic testing market, thereby providing interpretation of vast volumes of data to increase specificity and sensitivity.

Research Scope:
The key objectives of this growth opportunity study are to track the changes in the prenatal genetic testing market landscape in the United States from 2016 to 2021. The study aims to identify growth segments and disruptive companies for investment. Further, it provides an in-depth revenue and market share analysis of 4 key segments, namely, NIPT, carrier screening for cystic fibrosis, invasive tests, and miscarriage tests. The study highlights industry challenges, growth drivers and restraints, competitive developments, mergers and acquisitions, and investment opportunities. It also discusses the impact of Protecting Access to Medicare Act (PAMA) and the LDT guidelines issued by the FDA, identifies transforming business models, and makes strategic recommendations to understand market dynamics. The study also covers key trends and growth opportunities, game-changing companies, disruptive technologies, and strategic recommendations.

Key questions this study will answer include:
What are the long-term growth prospects in the market?
What are the other areas of growth outside NIPT? What are the opportunities to explore in carrier screening and miscarriage screening?
What are some of the innovative companies to action and to follow?
How should you price your tests to remain competitive in the market?
Who are the established market participants and what are their strategies to remain competent in this market?

RESEARCH: INFOGRAPHIC

This infographic presents a brief overview of the research, and highlights the key topics discussed in it.
Click image to view it in full size

Table of Contents

Purpose of This Experiential Study

5-step Process to Transformational Growth

Scope and Segmentation

Segment Overview

Market Engineering Measurements

Market Snapshot

5 Major Growth Opportunities

Strategic Imperatives for Prenatal Genetic Test Providers

Methodology

Market Definition—Prenatal Genetic Tests

Prevalence of Fetal Chromosomal Aneuploidies

Prenatal Tests Based on Trimesters

Value Chain

Major Regulatory Developments and Future Implications

Drivers and Restraints

Market Engineering Measurements

Revenue Forecast

Market Share by Type of Prenatal Genetic Tests

Prenatal Genetic Test Service Provider Landscape

Competitive Factors and Assessment

Service Provider Landscape by Key Portfolio and Technology

Market Overview

Revenue Forecast

Snapshot of Key Market Participants

NIPT Volumes

Market Share by Top Competitors

Market Overview

Revenue Forecast

Snapshot of Key Market Participants

Market Overview

Revenue Forecast

Snapshot of Key Market Participants

Market Overview

Revenue Forecast

Snapshot of Key Market Participants

Macro to Micro Visioning

Trend Analysis in Prenatal Genetic Testing

Key Merger, Acquisition, and Partnership Assessment

Disruptive Concepts, Launches, and Portfolio Diversifications

Growth Opportunity 1—Shift to NGS-based Tests with Present Adoption Rate of 60-65%

Growth Opportunity 2—Targeting Pregnant Women above the Age of 35

Growth Opportunity 3—Targeting Physicians and Genetic Counselors for Channel Marketing

Growth Opportunity 4—Bolstering Marketing Strategies by Providing Tieups with Pharmacies (CVS, Walgreens), IVD Clinics, and Retail Partners like Amazon

Growth Opportunity 5—Preparing Strategies Based on PAMA Regulations, LDT Guidelines and Healthcare Payer Policies

Growth Opportunity Matrix

Top Predictions

Legal Disclaimer

Abbreviations and Acronyms Used

List of Major Prenatal Genetic Testing Companies

Details Regarding the Various Technologies Used by Companies

NIPT Process

CF Carrier Screen Testing Process

Invasive Testing Process

Miscarriage Testing Process

List of Figures
  • 1. Prenatal Genetic Testing Market: Prevalence of Fetal Chromosomal Aneuploidies, US, 2016
  • 2. Prenatal Genetic Testing Market: Value Chain, US, 2016
  • 3. Impact of PAMA on LDT Pricing, US, 2018
  • 4. Impact of FDA on LDT Regulation, US, 2017
  • 5. Impact of FDA on DTC Regulation, US, 2017
  • 6. Prenatal Genetic Testing Market: Key Drivers and Restraints, US, 2017–2021
  • 7. Prenatal Genetic Testing Market: Market Engineering Measurements, US, 2016
  • 8. Prenatal Genetic Testing Market: Key Service Providers, US, 2016
  • 9. Prenatal Genetic Testing Market: Trends Ranked in Importance of Key Competitive Factors, US, 2016
  • 10. Prenatal Genetic Testing Market: Key Companies by Portfolio and Technology, US, 2016
  • 11. NIPT Market: Accuracy in Detection Rate of Genetic Abnormalities Using Various Methods During Pregnancy, US, 2016
  • 12. NIPT Market: Multi-faceted Growth, US, 2016–2021
  • 13. NIPT Market: Key Participants, US, 2016
  • 14. NIPT Market: Key Companies Providing NIPT and their Estimated Test Volumes, US, 2016
  • 15. Cystic Fibrosis Carrier Screening Testing Market: Multi-faceted Growth, US, 2016–2021
  • 16. Cystic Fibrosis Carrier Screening Testing Market: Key Participants, US, 2016
  • 17. Invasive Prenatal Testing Market: Comparison between Prenatal Invasive Tests: Amniocentesis and CVS, US, 2016
  • 18. Invasive Prenatal Testing Market: Slow Growth, US, 2016–2021
  • 19. Miscarriage Testing Market: Multi-faceted Growth, US, 2016–2021
  • 20. Miscarriage Testing Market: Key Participants, US, 2016
  • 21. Prenatal Genetic Testing Market: Key Merger, Acquisition, and Partnership Assessment, US, 2013–2016
  • 22. Prenatal Genetic Testing Market: Growth Opportunity Matrix, US, 2016
  • 23. Prenatal Genetic Testing Market: Details Regarding Various Technologies Used by Companies, US, 2016
List of Charts
  • 1. Prenatal Genetic Testing Market: Market Engineering Measurements, US, 2016
  • 2. Prenatal Genetic Testing Market: Revenue Forecast, US, 2016–2021
  • 3. Prenatal Genetic Testing Market: Market Share by Type, US, 2016 and 2021
  • 4. NIPT Market: Accuracy in Detection Rate of Genetic Abnormalities Using Various Methods During Pregnancy, US, 2016
  • 5. NIPT Market: Revenue Forecast, US, 2016–2021
  • 6. NIPT Market: Test Volume Breakdown, US, 2016
  • 7. Cystic Fibrosis Carrier Screening Testing Market: Revenue Forecast, US, 2016–2021
  • 8. Invasive Prenatal Testing Market: Revenue Forecast, US, 2016–2021
  • 9. Miscarriage Testing Market: Revenue Forecast, US, 2016–2021
Related Research
Prenatal genetic tests, which are predominantly used to test disorders such as aneuploidies in chromosomes 21, 18, and 13, and carrier screens, are gaining momentum in the United States due to enhanced assay outcomes through non-invasive methodologies, increased popularity through social media channels, and the growing number of women choosing to undergo pregnancy at an advanced maternal age. The growth in demand has led to a high level of merger and acquisition activity, apart from numerous collaborations, which in turn has bolstered the product portfolio of several companies in the women’s healthcare segment. With this accelerated growth, companies are exploring new avenues to market their products, thereby strategically tying up with IVF clinics, physicians, and OBGYNs. New business models like direct to consumer (DTC) are seeing increased uptake due to ease of use and hassle-free processing. Partnerships with Big Data companies will be the next big leap in the prenatal genetic testing market, thereby providing interpretation of vast volumes of data to increase specificity and sensitivity. Research Scope: The key objectives of this growth opportunity study are to track the changes in the prenatal genetic testing market landscape in the United States from 2016 to 2021. The study aims to identify growth segments and disruptive companies for investment. Further, it provides an in-depth revenue and market share analysis of 4 key segments, namely, NIPT, carrier screening for cystic fibrosis, invasive tests, and miscarriage tests. The study highlights industry challenges, growth drivers and restraints, competitive developments, mergers and acquisitions, and investment opportunities. It also discusses the impact of Protecting Access to Medicare Act (PAMA) and the LDT guidelines issued by the FDA, identifies transforming business models, and makes strategic recommendations to understand market dynamics. The study also covers key trends and growth opportunities, game-ch
More Information
No Index No
Podcast No
Table of Contents | Executive Dashboard~ || Purpose of This Experiential Study~ || 5-step Process to Transformational Growth~ || Scope and Segmentation~ || Segment Overview~ || Market Engineering Measurements~ || Market Snapshot~ || 5 Major Growth Opportunities~ || Strategic Imperatives for Prenatal Genetic Test Providers~ | Growth Environment—Market Overview~ || Methodology~ || Market Definition—Prenatal Genetic Tests~ || Prevalence of Fetal Chromosomal Aneuploidies~ || Prenatal Tests Based on Trimesters~ || Value Chain~ || Major Regulatory Developments and Future Implications~ || Drivers and Restraints~ | Growth Environment—Market Forecast~ || Market Engineering Measurements~ || Revenue Forecast~ || Market Share by Type of Prenatal Genetic Tests~ | Growth Environment—Competitive Playbook~ || Prenatal Genetic Test Service Provider Landscape~ || Competitive Factors and Assessment~ || Service Provider Landscape by Key Portfolio and Technology~ | Growth Environment—NIPT~ || Market Overview~ || Revenue Forecast~ || Snapshot of Key Market Participants~ || NIPT Volumes~ || Market Share by Top Competitors~ | Growth Environment—Carrier Screening Test for Cystic Fibrosis~ || Market Overview~ || Revenue Forecast~ || Snapshot of Key Market Participants ~ | Growth Environment—Invasive Prenatal Diagnostic Test~ || Market Overview~ || Revenue Forecast~ || Snapshot of Key Market Participants ~ | Growth Environment—Miscarriage Test~ || Market Overview~ || Revenue Forecast~ || Snapshot of Key Market Participants ~ | Visioning Scenarios~ || Macro to Micro Visioning~ || Trend Analysis in Prenatal Genetic Testing~ || Key Merger, Acquisition, and Partnership Assessment~ || Disruptive Concepts, Launches, and Portfolio Diversifications~ | Growth Opportunities~ || Growth Opportunity 1—Shift to NGS-based Tests with Present Adoption Rate of 60-65%~ || Growth Opportunity 2—Targeting Pregnant Women above the Age of 35~ || Growth Opportunity 3—Targeting Physicians and Genetic Counselors for Channel Marketing~ || Growth Opportunity 4—Bolstering Marketing Strategies by Providing Tieups with Pharmacies (CVS, Walgreens), IVD Clinics, and Retail Partners like Amazon~ || Growth Opportunity 5—Preparing Strategies Based on PAMA Regulations, LDT Guidelines and Healthcare Payer Policies~ || Growth Opportunity Matrix~ | Conclusion~ || Top Predictions~ || Legal Disclaimer~ | Appendix~ || Abbreviations and Acronyms Used~ || List of Major Prenatal Genetic Testing Companies~ || Details Regarding the Various Technologies Used by Companies~ || NIPT Process~ || CF Carrier Screen Testing Process~ || Invasive Testing Process~ || Miscarriage Testing Process~
List of Charts and Figures 1. Prenatal Genetic Testing Market: Prevalence of Fetal Chromosomal Aneuploidies, US, 2016~ 2. Prenatal Genetic Testing Market: Value Chain, US, 2016~ 3. Impact of PAMA on LDT Pricing, US, 2018~ 4. Impact of FDA on LDT Regulation, US, 2017~ 5. Impact of FDA on DTC Regulation, US, 2017~ 6. Prenatal Genetic Testing Market: Key Drivers and Restraints, US, 2017–2021~ 7. Prenatal Genetic Testing Market: Market Engineering Measurements, US, 2016~ 8. Prenatal Genetic Testing Market: Key Service Providers, US, 2016~ 9. Prenatal Genetic Testing Market: Trends Ranked in Importance of Key Competitive Factors, US, 2016~ 10. Prenatal Genetic Testing Market: Key Companies by Portfolio and Technology, US, 2016~ 11. NIPT Market: Accuracy in Detection Rate of Genetic Abnormalities Using Various Methods During Pregnancy, US, 2016~ 12. NIPT Market: Multi-faceted Growth, US, 2016–2021~ 13. NIPT Market: Key Participants, US, 2016~ 14. NIPT Market: Key Companies Providing NIPT and their Estimated Test Volumes, US, 2016~ 15. Cystic Fibrosis Carrier Screening Testing Market: Multi-faceted Growth, US, 2016–2021~ 16. Cystic Fibrosis Carrier Screening Testing Market: Key Participants, US, 2016~ 17. Invasive Prenatal Testing Market: Comparison between Prenatal Invasive Tests: Amniocentesis and CVS, US, 2016~ 18. Invasive Prenatal Testing Market: Slow Growth, US, 2016–2021~ 19. Miscarriage Testing Market: Multi-faceted Growth, US, 2016–2021~ 20. Miscarriage Testing Market: Key Participants, US, 2016~ 21. Prenatal Genetic Testing Market: Key Merger, Acquisition, and Partnership Assessment, US, 2013–2016~ 22. Prenatal Genetic Testing Market: Growth Opportunity Matrix, US, 2016~ 23. Prenatal Genetic Testing Market: Details Regarding Various Technologies Used by Companies, US, 2016~| 1. Prenatal Genetic Testing Market: Market Engineering Measurements, US, 2016~ 2. Prenatal Genetic Testing Market: Revenue Forecast, US, 2016–2021~ 3. Prenatal Genetic Testing Market: Market Share by Type, US, 2016 and 2021~ 4. NIPT Market: Accuracy in Detection Rate of Genetic Abnormalities Using Various Methods During Pregnancy, US, 2016~ 5. NIPT Market: Revenue Forecast, US, 2016–2021~ 6. NIPT Market: Test Volume Breakdown, US, 2016~ 7. Cystic Fibrosis Carrier Screening Testing Market: Revenue Forecast, US, 2016–2021~ 8. Invasive Prenatal Testing Market: Revenue Forecast, US, 2016–2021~ 9. Miscarriage Testing Market: Revenue Forecast, US, 2016–2021~
Author Supratik Paul
Industries Healthcare
WIP Number K1C4-01-00-00-00
Is Prebook No